Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections

Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025.

Antranik Tavitian | Reuters